Abstract
Although arthritis is the most notable component, rheumatoid arthritis (RA) is a systemic inflammatory disorder where extra-articular manifestations are common; among them, central and peripheral nervous system involvement is frequent and associated with significant morbidity and, in some cases, reduced life span. It may produce a myriad of symptoms and signs ranging from subtle numbness in a hand, to quadriparesis and sudden death. Central and peripheral neurologic manifestations may arise from structural damage produced by RA in diarthroidal joints, by the systemic inflammatory process of the disease itself or by the drugs used to treat it. Neurologic syndromes may appear suddenly or developed slowly through months, and emerge early or after years of having RA. Neurologic manifestations may be easily overlooked or incorrectly assigned to peripheral arthritis unless the attending physician is aware of these complications. In this article, we review neurologic involvement in RA patients with emphasis on clinical approach for early detection.
Similar content being viewed by others
References
Ramos-Remus C, Sierra-Jimenez G, Skeith K et al (2007) Latitude gradient influences the age of onset in rheumatoid arthritis patients. Clin Rheumatol 26:1725–1728
Badley EM (2008) Rheumatic diseases: the unnoticed elephant in the room. J Rheumatol 35:6–7
Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903–911
Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA (2005) Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 32:1459–1456
Agarwal V, Singh R, Wiclaf et al (2008) A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol 27:841–844
Steinber VL (1960) Neuropathy in rheumatoid disease. Br Med J 1:1600–1603
Weller RO, Bruckner FE, Chamberlain MA (1970) Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry 33:592–604
Pallis CA, Scott JT (1965) Peripheral neuropathy in rheumatoid arthritis. Br Med J 1:1141–1147
Chamberlain MA, Bruckner FE (1970) Rheumatoid neuropathy. Clinical and electrophysiological features. Ann Rheum Dis 29:609–616
Lanzillo B, Pappone N, Crisci C et al (1998) Subclinical peripheral nerve involvement in patients with rheumatoid arthritis. Arthritis Rheum 41:1196–1202
Good AE, Christipher RP, Koepke GH, Bender LF, Tarter ME (1965) Peripheral neuropathy associated with rheumatoid arthritis: a clinical and electrodiagnostic study of 70 consecutive rheumatoid arthritis patients. Ann Intern Med 63:87–99
Genta MS, Genta RM, Gabay C (2006) Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 36:88–98
Singhal BS, Khadilkar SV, Gursahani RD, Surya N (1995) Vasculitic neuropathy: profile of twenty patients. J Assoc Physicians India 43:459–461
Richter C, Wanke L, Steinmetz J, Reinhold-Keller E, Gross WL (2000) Mononeuritis secondary to rheumatoid arthritis responds to etanercept. Rheumatology (Oxford) 39:1436–1437
Mayer DF, Matteson EL (2004) Testicular involvement in rheumatoid vasculitis. Clin Exp Rheumatol 22:S62–S64
Puechal X, Said G, Hilliquin P et al (1995) Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 38:1618–1629
Chatterjee S, Kupsky WJ (2005) Severe proximal myopathy and mononeuritis multiplex in rheumatoid arthritis: manifestations of rheumatoid vasculitis. J Clin Rheumatol 11:50–55
Armstrong DJ, McCarron MT, Wright GD (2005) Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab. J Rheumatol 32:759–760
Bayrak AO, Durmus D, Durmaz Y et al (2010) Electrophysiological assessment of polyneuropathic involvement in rheumatoid arthritis: relationships among demographic, clinical and laboratory findings. Neurol Res 32:711–714
Conn DL, McDuffie FC, Dyck PJ (1972) Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 15:135–143
Scott DG, Bacon PA, Tribe CR (1981) Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 60:288–297
Muramatsu K, Tanaka H, Taguchi T (2008) Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment. Rheumatol Int 28:951–957
Canoso JJ, Alvarez-Nemegyei J (2006) Soft tissue rheumatology. In: Lahita RG, Weinstein A (eds) Educational review manual in rheumatology, 3rd edn. Castle Connolly Graduate Medical, New York
Cardenaz Diaz RI, Hernandez Hernandez M, Ramos-Remus C (1994) Anastomosis de Martin–Gruber: Estudio electrofisiológico. Rev Mex Reumatol 9:125–129
Boland RA, Kiernan MC (2009) Assessing the accuracy of a combination of clinical tests for identifying carpal tunnel syndrome. J Clin Neurosci 16:929–933
El MY, Ashour S, Youssef S, Mehanna A, Meky FA (2008) Clinical diagnosis of carpal tunnel syndrome: old tests–new concepts. Jt Bone Spine 75:451–457
Ogawa H, Akaike A, Ishimaru D et al (2007) Posterior interosseous nerve palsy related to rheumatoid synovitis of the elbow. Mod Rheumatol 17:327–329
Sharp RJ, Wade CM, Hennessy MS, Saxby TS (2003) The role of MRI and ultrasound imaging in Morton’s neuroma and the effect of size of lesion on symptoms. J Bone Jt Surg Br 85:999–1005
Ito H, Neo M, Sakamoto T et al (2009) Subaxial subluxation after atlantoaxial transarticular screw fixation in rheumatoid patients. Eur Spine J 18:869–876
Collins DN, Barnes CL, FitzRandolph RL (1991) Cervical spine instability in rheumatoid patients having total hip or knee arthroplasty. Clin Orthop Relat Res 127–135
Neva MH, Kaarela K, Kauppi M (2000) Prevalence of radiological changes in the cervical spine—a cross sectional study after 20 years from presentation of rheumatoid arthritis. J Rheumatol 27:90–93
Fujiwara K, Fujimoto M, Owaki H et al (1998) Cervical lesions related to the systemic progression in rheumatoid arthritis. Spine (Phila Pa 1976) 23:2052–2056
Paimela L, Laasonen L, Kankaanpaa E, Leirisalo-Repo M (1997) Progression of cervical spine changes in patients with early rheumatoid arthritis. J Rheumatol 24:1280–1284
Coutts MB (1934) Atlanto-epistropheal subluxation. Arch Surg 29:297–311
Babini SM, Cocco JA, Babini JC et al (1990) Atlantoaxial subluxation in systemic lupus erythematosus: further evidence of tendinous alterations. J Rheumatol 17:173–177
Stuart RA, Maddison PJ (1991) Atlantoaxial subluxation in a patient with mixed connective tissue disease. J Rheumatol 18:1617–1620
Laiho K, Kauppi M (2002) The cervical spine in patients with psoriatic arthritis. Ann Rheum Dis 61:650–652
Fox B, Sahuquillo J, Poca MA, Huguet P, Lience E (1997) Reactive arthritis with a severe lesion of the cervical spine. Br J Rheumatol 36:126–129
Jordan JM, Obeid LM, Allen NB (1986) Isolated atlantoaxial subluxation as the presenting manifestation of inflammatory bowel disease. Am J Med 80:517–520
Koss JC, Dalinka MK (1980) Atlantoaxial subluxation in Behcet’s syndrome. AJR Am J Roentgenol 134:392–393
Daumen-Legre V, Lafforgue P, Champsaur P et al (1999) Anteroposterior atlantoaxial subluxation in cervical spine osteoarthritis: case reports and review of the literature. J Rheumatol 26:687–691
Takasita M, Matsumoto H, Uchinou S, Tsumura H, Torisu T (2000) Atlantoaxial subluxation associated with ossification of posterior longitudinal ligament of the cervical spine. Spine 25:2133–2136
Verdone F (1999) Anterior atlantoaxial subluxation in a patient with DISH. J Rheumatol 26:1639–1640
Herzka A, Sponseller PD, Pyeritz RE (2000) Atlantoaxial rotatory subluxation in patients with Marfan syndrome. A report of three cases. Spine 25:524–526
Shewell PC, Thompson AG (1996) Atlantoaxial instability in Lesch-Nyhan syndrome. Spine 21:757–762
Bland JH (1990) Rheumatoid subluxation of the cervical spine. J Rheumatol 17:134–137
Sharp J, Purser DW (1961) Spontaneous atlanto-axial dislocation in ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 20:47–77
Martel W (1961) The occipito-atlanto-axial joints in rheumatoid arthritis and ankylosing spondylitis. Am J Roentgenol Radium Ther Nucl Med 86:223–240
Castro S, Verstraete K, Mielants H et al (1994) Cervical spine involvement in rheumatoid arthritis: a clinical, neurological and radiological evaluation. Clin Exp Rheumatol 12:369–374
Komusi T, Munro T, Harth M (1985) Radiologic review: the rheumatoid cervical spine. Semin Arthritis Rheum 14:187–195
Zikou AK, Alamanos Y, Argyropoulou MI et al (2005) Radiological cervical spine involvement in patients with rheumatoid arthritis: a cross sectional study. J Rheumatol 32:801–806
Pisitkun P, Pattarowas C, Siriwongpairat P et al (2004) Reappraisal of cervical spine subluxation in Thai patients with rheumatoid arthritis. Clin Rheumatol 23:14–18
Younes M, Belghali S, Kriaa S et al (2009) Compared imaging of the rheumatoid cervical spine: prevalence study and associated factors. Jt Bone Spine 76:361–368
Resnick D, Niwayama G (1995) Anatomy of individual joints. In: Resnick D (ed) Diagnosis of bone and joint disorders. Saunders, Philadelphia, pp 672–768
Bland JH, Boushey DR (1990) Anatomy and physiology of the cervical spine. Semin Arthritis Rheum 20:1–20
Jackson H (1950) The diagnosis of minimal atlanto-axial subluxation. Br J Radiol 23:672–674
Hinck VC, Hopkins CE (1960) Measurement of the atlanto-dental interval in the adult. Am J Roentgenol Radium Ther Nucl Med 84:945–951
Ramos-Remus C, Gomez-Vargas A, Guzman-Guzman JL et al (1995) Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. J Rheumatol 22:2120–2125
Ramos-Remus C, Gomez-Vargas A, Hernandez-Chavez A et al (1997) Two year followup of anterior and vertical atlantoaxial subluxation in ankylosing spondylitis. J Rheumatol 24:507–510
Boden SD, Dodge LD, Bohlman HH, Rechtine GR (1993) Rheumatoid arthritis of the cervical spine. A long-term analysis with predictors of paralysis and recovery. J Bone Jt Surg Am 75:1282–1297
Kim DH, Hilibrand AS (2005) Rheumatoid arthritis in the cervical spine. J Am Acad Orthop Surg 13:463–474
Kauppi M, Sakaguchi M, Konttinen YT, Hamalainen M (1990) A new method of screening for vertical atlantoaxial dislocation. J Rheumatol 17:167–172
Eulderink F, Meijers KA (1976) Pathology of the cervical spine in rheumatoid arthritis: a controlled study of 44 spines. J Pathol 120:91–108
Bouchaud-Chabot A, Liote F (2002) Cervical spine involvement in rheumatoid arthritis. A review. Jt Bone Spine 69:141–154
Raskin RJ, Schnapf DJ, Wolf CR, Killian PJ, Lawless OJ (1983) Computerized tomography in evaluation of atlantoaxial subluxation in rheumatoid arthritis. J Rheumatol 10:33–41
Braunstein EM, Weissman BN, Seltzer SE et al (1984) Computed tomography and conventional radiographs of the craniocervical region in rheumatoid arthritis. A comparison. Arthritis Rheum 27:26–31
Breedveld FC, Algra PR, Vielvoye CJ, Cats A (1987) Magnetic resonance imaging in the evaluation of patients with rheumatoid arthritis and subluxations of the cervical spine. Arthritis Rheum 30:624–629
Stiskal MA, Neuhold A, Szolar DH et al (1995) Rheumatoid arthritis of the craniocervical region by MR imaging: detection and characterization. AJR Am J Roentgenol 165:585–592
Bell GR, Stearns KL (1991) Flexion–extension MRI of the upper rheumatoid cervical spine. Orthopedics 14:969–973
Neva MH, Hakkinen A, Makinen H et al (2006) High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery. Ann Rheum Dis 65:884–888
Lopez-Olivo MA, Andrabi PR, Palla SL, Suarez-Almazor ME (2011) Use of cervical spine radiographs in patients with rheumatoid arthritis undergoing general anesthesia. Clin Rheumatol (in press)
Messeter KH, Pettersson KI (1980) Endotracheal intubation with the fibre-optic bronchoscope. Anaesthesia 35:294–298
Riise T, Jacobsen BK, Gran JT (2001) High mortality in patients with rheumatoid arthritis and atlantoaxial subluxation. J Rheumatol 28:2425–29
Paus AC, Steen H, Roislien J, Mowinckel P, Teigland J (2008) High mortality rate in rheumatoid arthritis with subluxation of the cervical spine$$ a cohort study of operated and nonoperated patients. Spine (Phila PA 1976) 33:2278–2283
Shoda N, Seichi A, Takeshita K et al (2009) Sleep apnea in rheumatoid arthritis patients with occipitocervical lesions: the prevalence and associated radiographic features. Eur Spine J 18:905–910
Zikou AK, Argyropoulou MI, Voulgari PV et al (2006) Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab. J Rheumatol 33:219–223
Mukai Y, Hosono N, Sakaura H et al (2007) Sagittal alignment of the subaxial cervical spine after C1–C2 transarticular screw fixation in rheumatoid arthritis. J Spinal Disord Tech 20:436–441
Mrabet D, Meddeb N, Ajlani H, Sahli H, Sellami S (2007) Cerebral vasculitis in a patient with rheumatoid arthritis. Joint Bone Spine 74:201–204
Chowdhry V, Kumar N, Lachance DH, Salomao DR, Luthra HS (2005) An unusual presentation of rheumatoid meningitis. J Neuroimaging 15:286–288
Bathon JM, Moreland LW, DiBartolomeo AG (1989) Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthritis Rheum 18:258–266
Markenson JA, McDougal JS, Tsairis P, Lockshin MD, Christian CL (1979) Rheumatoid meningitis: a localized immune process. Ann Intern Med 90:786–789
Jackson CG, Chess RL, Ward JR (1984) A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 11:237–240
Schmid L, Muller M, Treumann T et al (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60:1632–1634
Catananti C, Mastropaolo S, Calabrese C, Silveri MC, Onder G (2010) A case of normal-pressure hydrocephalus associated with rheumatoid arthritis. Aging Clin Exp Res 22:189–191
Bruggemann N, Gottschalk S, Holl-Ulrich K et al (2010) Cranial pachymeningitis: a rare neurological syndrome with heterogeneous aetiology. J Neurol Neurosurg Psychiatry 81:294–298
Ikeda K, Takazawa T, Ito H et al (2010) Rheumatoid leptomeningitis: radiological alteration of cerebral hypoperfusion and subarachnoid lesions. Intern Med 49:1911–1916
Schilling U, Muck R, Heidemann E (2004) Lead poisoning after ingestion of ayurvedic drugs. Med Klin (Munich) 99:476–480
Karri SK, Saper RB, Kales SN (2008) Lead encephalopathy due to traditional medicines. Curr Drug Saf 3:54–59
Benyamin RM, Vallejo R, Kramer J, Rafeyan R (2008) Corticosteroid induced psychosis in the pain management setting. Pain Physician 11:917–920
Perantie DC, Brown ES (2002) Corticosteroids, immune suppression, and psychosis. Curr Psychiatry Rep 4:171–176
Wolkowitz OM, Lupien SJ, Bigler E, Levin RB, Canick J (2004) The “steroid dementia syndrome”: an unrecognized complication of glucocorticoid treatment. Ann N Y Acad Sci 1032:191–194
Brown ES, Chandler PA (2001) Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry 3:17–21
Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111–122
Sapolsky RM (1996) Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1:1–19
Alderson AL, Novack TA (2002) Neurophysiological and clinical aspects of glucocorticoids and memory: a review. J Clin Exp Neuropsychol 24:335–355
Gonzalez-Perez O, Ramos-Remus C, Garcia-Estrada J, Luquin S (2001) Prednisone induces anxiety and glial cerebral changes in rats. J Rheumatol 28:2529–2534
Ramos-Remus C, Gonzalez-Castaneda RE, Gonzalez-Perez O, Luquin S, Garcia-Estrada J (2002) Prednisone induces cognitive dysfunction, neuronal degeneration, and reactive gliosis in rats. J Investig Med 50:458–464
Hoppmann RA, Peden JG, Ober SK (1991) Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Aseptic meningitis, psychosis, and cognitive dysfunction. Arch Intern Med 151:1309–1313
Rodriguez SC, Olguin AM, Miralles CP, Viladrich PF (2006) Characteristics of meningitis caused by Ibuprofen: report of 2 cases with recurrent episodes and review of the literature. Medicine (Baltimore) 85:214–220
Simon LS, Mills JA (1980) Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts). N Engl J Med 302:1179–1185
Horn AC, Jarrett SW (1997) Ibuprofen-induced aseptic meningitis in rheumatoid arthritis. Ann Pharmacother 31:1009–1011
Quinn CT, Kamen BA (1996) A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Investig Med 44:522–530
Hawboldt J, Bader M (2007) Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 41:1906–1911
Rynes RI (1996) Ophthalmologic considerations in using antimalarials in the United States. Lupus 5(Suppl 1):S73–S74
Rynes RI (1997) Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 36:799–805
Johansen PB, Gran JT (1998) Ototoxicity due to hydroxychloroquine: report of two cases. Clin Exp Rheumatol 16:472–474
Seckin U, Ozoran K, Ikinciogullari A, Borman P, Bostan EE (2000) Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatol Int 19:203–204
Hadi U, Nuwayhid N, Hasbini AS (1996) Chloroquine ototoxicity: an idiosyncratic phenomenon. Otolaryngol Head Neck Surg 114:491–493
Bernard P (1985) Alterations of auditory evoked potentials during the course of chloroquine treatment. Acta Otolaryngol 99:387–392
Scherbel AL, Harrison JW, Atdjian M (1958) Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases. Cleve Clin Q 25:95–111
Meier CR, Wilcock K, Jick SS (2004) The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf 27:203–213
Avina-Zubieta JA, Johnson ES, Suarez-Almazor ME, Russell AS (1995) Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature. Br J Rheumatol 34:166–170
Casado E, Gratacos J, Tolosa C et al (2006) Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients. Ann Rheum Dis 65:385–390
Richards BL, Spies J, McGill N et al (2007) Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Intern Med J 37:101–107
Antonio-Valdiviezo A, Pena-Santos G, Martinez-Torres J (2010) Peripheral neuropathy caused by leflunomide. A case reported with a brief review. Rev Med Inst Mex Seguro Soc 48:567–570
Bonnel RA, Graham DJ (2004) Peripheral neuropathy in patients treated with leflunomide. Clin Pharmacol Ther 75:580–585
Martin K, Bentaberry F, Dumoulin C et al (2005) Neuropathy associated with leflunomide: a case series. Ann Rheum Dis 64:649–650
Martin K, Bentaberry F, Dumoulin C et al (2007) Peripheral neuropathy associated with leflunomide: is there a risk patient profile? Pharmacoepidemiol Drug Saf 16:74–78
Bharadwaj A, Haroon N (2004) Peripheral neuropathy in patients on leflunomide. Rheumatology (Oxford) 43:934
Tilelli JA, Heinrichs MM (1997) Adverse reactions to parenteral gold salts. Lancet 349:853
Fam AG, Gordon DA, Sarkozi J et al (1984) Neurologic complications associated with gold therapy for rheumatoid arthritis. J Rheumatol 11:700–706
Petiot P, Charles N, Vial C et al (1993) Neurological complications caused by gold salts. Nosologic report apropos of a case. Rev Neurol (Paris) 149:562–565
Goy JJ, Stauffer JC, Deruaz JP et al (1989) Myopathy as possible side-effect of cyclosporin. Lancet 1:1446–1447
Noppen M, Velkeniers B, Dierckx R, Bruyland M, Vanhaelst L (1987) Cyclosporine and myopathy. Ann Intern Med 107:945–946
Owczarek J, Jasinska M, Orszulak-Michalak D (2005) Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 57:23–34
Schwartz RB, Bravo SM, Klufas RA et al (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 165:627–631
Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339–346
Kumar D, Bouldin TW, Berger RG (2010) A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab. Arthritis Rheum 62:3191–3195
Lozeron P, Denier C, Lacroix C, Adams D (2009) Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol 66:490–497
Kur-Zalewska J, Swarowska-Knap J, Tlustochowicz W (2008) Neurological disorders with demyelinating brain white matter lesions in a patient with rheumatoid arthritis treated with etanercept. Pol Arch Med Wewn 118:234–237
Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862–2869
Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN (2006) Guillain–Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54:1429–1434
Alshekhlee A, Basiri K, Miles JD, Ahmad SA, Katirji B (2010) Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists. Muscle Nerve 41:723–727
Bosch X, Saiz A, Ramos-Casals M (2011) Monoclonal antibody therapy-associated neurological disorders. Nat Rev Neurol 7:165–172
Lynch K, Farrell M (2010) Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatment. Clin Rheumatol 29:1201–1204
Calabrese LH, Molloy ES (2008) Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies. Ann Rheum Dis 67(Suppl 3):iii64–iii65
Food and Drug Administration (2009) http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150747.htm. Accessed 06/August/2009
Carson KR, Focosi D, Major EO et al (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10:816–824
Lima MA, Drislane FW, Koralnik IJ (2006) Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 66:262–264
Alloway JA, Mitchell SR (1993) Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature. J Rheumatol 20:409–411
Takahashi K, Ogita T, Okudaira H et al (1986) d-Penicillamine-induced polymyositis in patients with rheumatoid arthritis. Arthritis Rheum 29:560–564
Chappel R, Willems J (1996) d-Penicillamine-induced myositis in rheumatoid arthritis. Clin Rheumatol 15:86–87
Carroll GJ, Will RK, Peter JB, Garlepp MJ, Dawkins RL (1987) Penicillamine induced polymyositis and dermatomyositis. J Rheumatol 14:995–1001
Halla JT, Fallahi S, Koopman WJ (1984) Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature. Am J Med 77:719–722
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramos-Remus, C., Duran-Barragan, S. & Castillo-Ortiz, J.D. Beyond the joints. Clin Rheumatol 31, 1–12 (2012). https://doi.org/10.1007/s10067-011-1841-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1841-z